S
Sanbo Brain Hospital
Specialized neurological hospital group integrating medical, educational, research
About Sanbo Brain Hospital
Sanbo Brain Hospital Management Group is a specialized hospital network in China focused on neuroscience, established in 2003 by neurology experts Luan Guoming, Yu Chunjiang, Shi Xiang'en, and hospital management expert Zhang Yang. The group was founded on an "academy-like" model that integrates clinical medical services with education and research, allowing its physicians to engage in academic activities. This structure is designed to attract top clinical talent by addressing common private hospital limitations regarding research, teaching, and professional titles.
The business operates as a chain of hospitals with a "strong specialty, small comprehensive" development approach, creating a medical service network across China's core regions. Its flagship institution, the Capital Medical University Sanbo Brain Hospital in Beijing, was founded in 2004 and serves as a national clinical key specialist in neurosurgery and a residency training base. The group has expanded by building new hospitals and restructuring existing ones, operating eight hospitals with more under construction. The business generates revenue through the provision of medical services to patients, covering a wide range of neurological conditions including brain tumors, epilepsy, and cerebrovascular diseases, as well as general medical fields.
Sanbo's services cater to patients from across China and internationally. Annually, the group handles nearly 990,000 outpatient visits, over 65,000 inpatients, and performs more than 20,000 surgeries, with over 7,000 being neurosurgical procedures. The flagship Beijing hospital is equipped with advanced technology such as a 306-channel magnetoencephalogram (MEG) and the ROSA, a robotized stereotactic assistant for neurosurgery. On May 5, 2023, the group was successfully listed on the Shenzhen Stock Exchange, becoming the first private neuro-specialty hospital to go public in China.
Source: Dealroom company dataNews
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES BOther financing | May 2020 | $110M | $440M | GF Xinde Investment · CEC Capital Future Fund | ↗ |
| SERIES AOther financing | Nov 2017 | — | — | Kaitai Capital | — |
Growth signals
Latest recorded traffic for Sanbo Brain Hospital is 4K monthly website visits, down 16.7% over the last three months. Sanbo Brain Hospital's team grew 0% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Sanbo Brain Hospital in its local ecosystem
The Sanbo Brain Hospital office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A3 investors entered at this stage
- KCKaitai Capital
- GIGF Xinde Investment
- CFCEC Capital Future Fund
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Sanbo Brain Hospital on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Sanbo Brain Hospital’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







